98 related articles for article (PubMed ID: 16970922)
1. Anti-angiogenesis and anti-tumor activity of recombinant anginex.
Brandwijk RJ; Dings RP; van der Linden E; Mayo KH; Thijssen VL; Griffioen AW
Biochem Biophys Res Commun; 2006 Oct; 349(3):1073-8. PubMed ID: 16970922
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenesis and anti-tumor effects of AdNT4-anginex.
Dong DF; Li EX; Wang JB; Wu YY; Shi F; Guo JJ; Wu Y; Liu JP; Liu SX; Yang GX
Cancer Lett; 2009 Nov; 285(2):218-24. PubMed ID: 19540664
[TBL] [Abstract][Full Text] [Related]
3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
4. Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein.
Brandwijk RJ; Nesmelova I; Dings RP; Mayo KH; Thijssen VL; Griffioen AW
Biochem Biophys Res Commun; 2005 Aug; 333(4):1261-8. PubMed ID: 15979575
[TBL] [Abstract][Full Text] [Related]
5. The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.
van der Schaft DW; Dings RP; de Lussanet QG; van Eijk LI; Nap AW; Beets-Tan RG; Bouma-Ter Steege JC; Wagstaff J; Mayo KH; Griffioen AW
FASEB J; 2002 Dec; 16(14):1991-3. PubMed ID: 12397082
[TBL] [Abstract][Full Text] [Related]
6. The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin.
Dings RP; Yokoyama Y; Ramakrishnan S; Griffioen AW; Mayo KH
Cancer Res; 2003 Jan; 63(2):382-5. PubMed ID: 12543791
[TBL] [Abstract][Full Text] [Related]
7. A recombinant human RNASET2 glycoprotein with antitumorigenic and antiangiogenic characteristics: expression, purification, and characterization.
Smirnoff P; Roiz L; Angelkovitch B; Schwartz B; Shoseyov O
Cancer; 2006 Dec; 107(12):2760-9. PubMed ID: 17109444
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
Bandyopadhyay A; López-Casillas F; Malik SN; Montiel JL; Mendoza V; Yang J; Sun LZ
Cancer Res; 2002 Aug; 62(16):4690-5. PubMed ID: 12183427
[TBL] [Abstract][Full Text] [Related]
9. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
10. Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways.
Ma K; Wang C; Geng Q; Fan Y; Ning J; Yang H; Dong X; Dong D; Guo Y; Wei X; Li E; Wu Y
Oncol Rep; 2016 Jun; 35(6):3505-13. PubMed ID: 27035232
[TBL] [Abstract][Full Text] [Related]
11. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells.
Dings RP; Williams BW; Song CW; Griffioen AW; Mayo KH; Griffin RJ
Int J Cancer; 2005 Jun; 115(2):312-9. PubMed ID: 15688384
[TBL] [Abstract][Full Text] [Related]
12. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
13. Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results.
Yang F; Li Z; Deng H; Yang H; Yan F; Qian Z; Chen L; Wei Y; Zhao X
Oncology; 2008; 75(3-4):137-44. PubMed ID: 18824876
[TBL] [Abstract][Full Text] [Related]
14. Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities.
Dings RP; Chen X; Hellebrekers DM; van Eijk LI; Zhang Y; Hoye TR; Griffioen AW; Mayo KH
J Natl Cancer Inst; 2006 Jul; 98(13):932-6. PubMed ID: 16818857
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer.
Schmitz V; Raskopf E; Gonzalez-Carmona MA; Vogt A; Kornek M; Sauerbruch T; Caselmann WH
Cancer Invest; 2008 Jun; 26(5):464-70. PubMed ID: 18568768
[TBL] [Abstract][Full Text] [Related]
16. [Construction and activity of recombinant adeno-associated virus expressing vasostatin].
Diao Y; Ma J; Li X; Sun X; Xu R
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1949-54. PubMed ID: 19256344
[TBL] [Abstract][Full Text] [Related]
17. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
Hoffmann S; Rockenstein A; Ramaswamy A; Celik I; Wunderlich A; Lingelbach S; Hofbauer LC; Zielke A
Mol Cell Endocrinol; 2007 Jan; 264(1-2):74-81. PubMed ID: 17101211
[TBL] [Abstract][Full Text] [Related]
19. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
20. Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent.
Wang JB; Wang MD; Li EX; Dong DF
Peptides; 2012 Dec; 38(2):457-62. PubMed ID: 22985857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
